Form 8-K CATALYST PHARMACEUTICAL For: Aug 14
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140814/A72ZG22FZ22R42ZZ2R2K2MXRLE5AZZ22Z862
Filed on: August 14, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
- REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
- Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
